Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Myelodysplastic Syndromes 15Hematologic Neoplasms 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Lymphoma, Non-Hodgkin 6Neuroblastoma 5Leukemia, Biphenotypic, Acute 5Myeloproliferative Disorders 4Graft vs Host Disease 4Multiple Myeloma 3Medulloblastoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia 3Hodgkin Disease 3Ganglioneuroblastoma 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Lymphoma 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory, with Excess of Blasts 2Teratoma 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Neurofibrosarcoma 1

Interventions

Cyclophosphamide 51fludarabine 37Dexamethasone 35venetoclax 30pembrolizumab 25Rituximab 20pomalidomide 18Lenalidomide 17Gemcitabine 17fludarabine phosphate 15Etoposide 14Cytarabine 13daratumumab 12carfilzomib 11Temozolomide 11Injections 10Calcium Dobesilate 10glofitamab 9Nivolumab 9Cisplatin 9Bortezomib 9Azacitidine 9selinexor 8Vincristine 8Immunotherapy, Adoptive 8obinutuzumab 7cemiplimab 7Drug Therapy 7Carboplatin 7zanubrutinib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Thiotepa × 1 year × Clear all
NCT07257419 2026-05-19

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

St. Jude Children's Research Hospital

Phase 1 Recruiting
70 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡